Literature DB >> 35089306

Associations of Visual Function With Cognitive Performance in Community-Based Older Adults: The Eye Determinants of Cognition Study.

Lubaina T Arsiwala1, Xinxing Guo1, Pradeep Y Ramulu1,2, A Richey Sharrett2, Aleksandra Mihailovic1, Bonnielin K Swenor1,2, Thomas Mosley3,4, YaNan Dong2, Alison G Abraham2,5,6.   

Abstract

BACKGROUND: Given the detrimental impacts of visual and cognitive impairment separately, in older adults, understanding their coexistence could inform strategies against age-related cognitive changes.
METHODS: Participants from Washington County (White) and Jackson (Black) sites of the Atherosclerosis Risk in Communities Study were recruited who differed on racial, regional, urbanicity, and community-based factors. Presenting distance visual acuity (DVA; representing vision loss due to disease or lack of eye-care), corrected DVA (representing optimal correction for refractive loss of vision), and contrast sensitivity were measured. Factor scores for global cognition, memory, executive function, and language domains were calculated for 3 visits. We quantified the associations of vision measures with change in cognitive scores, stratified by community/race, using generalized estimating equations.
RESULTS: In 982 participants, mean (standard deviation [SD]) baseline age was 74 (4) years, with 37% males and 45% Jackson/Black participants. As hypothesized, after accounting for potential confounders, in the better-eye, worse presenting DVA was associated with greater 10-year decline rate in global cognition, memory, and executive function in Washington County/White participants (eg, global cognition: -0.08 SD [95% confidence interval: -0.12, -0.04]). Worse corrected DVA was associated with greater 10-year decline rate in executive function in Washington County/White participants (-0.10 SD [-0.15, -0.04]). Better contrast sensitivity was associated with lower 10-year decline rate in global cognition and executive function in Washington County/White participants (eg, global cognition: 0.10 SD [0.06,0.14]). None of these associations were confirmed in Jackson/Black participants.
CONCLUSIONS: Our study supports a functional link between some vision measures and cognition in older adults, but in only 1 of the 2 communities studied.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Brain; Community/race; Contrast sensitivity; Distance visual acuity; Sensory

Mesh:

Year:  2022        PMID: 35089306      PMCID: PMC9536449          DOI: 10.1093/gerona/glab349

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.591


  44 in total

1.  Confirmatory factor analysis of the ADNI Neuropsychological Battery.

Authors:  Lovingly Quitania Park; Alden L Gross; Donald G McLaren; Judy Pa; Julene K Johnson; Meghan Mitchell; Jennifer J Manly
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16.

Authors:  Traci E Clemons; Molly W Rankin; Wendy L McBee
Journal:  Arch Ophthalmol       Date:  2006-04

Review 3.  Economic research on Alzheimer disease: a review of the literature.

Authors:  R L Ernst; J W Hay
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

4.  Age-related eye disease and cognitive function.

Authors:  Hanen Harrabi; Marie-Jeanne Kergoat; Jacqueline Rousseau; Hélène Boisjoly; Heidi Schmaltz; Solmaz Moghadaszadeh; Marie-Hélène Roy-Gagnon; Ellen E Freeman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-03       Impact factor: 4.799

5.  Vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women.

Authors:  Michael Y Lin; Peter R Gutierrez; Katie L Stone; Kristine Yaffe; Kristine E Ensrud; Howard A Fink; Catherine A Sarkisian; Anne L Coleman; Carol M Mangione
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

6.  Vision health disparities in the United States by race/ethnicity, education, and economic status: findings from two nationally representative surveys.

Authors:  Xinzhi Zhang; Mary Frances Cotch; Asel Ryskulova; Susan A Primo; Parvathy Nair; Chiu-Fang Chou; Linda S Geiss; Lawrence E Barker; Amanda F Elliott; John E Crews; Jinan B Saaddine
Journal:  Am J Ophthalmol       Date:  2012-12       Impact factor: 5.258

7.  Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community.

Authors:  J R Evans; A E Fletcher; R P L Wormald; E Siu-Woon Ng; S Stirling; L Smeeth; E Breeze; C J Bulpitt; M Nunes; D Jones; A Tulloch
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

8.  Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study.

Authors:  Rebecca F Gottesman; Andreea M Rawlings; A Richey Sharrett; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura H Coker; Josef Coresh; David J Couper; Michael E Griswold; Gerardo Heiss; David S Knopman; Mehul D Patel; Alan D Penman; Melinda C Power; Ola A Selnes; Andrea L C Schneider; Lynne E Wagenknecht; B Gwen Windham; Lisa M Wruck; Thomas H Mosley
Journal:  Am J Epidemiol       Date:  2014-03-13       Impact factor: 4.897

9.  Validity of screening instruments for the detection of dementia and mild cognitive impairment in hospital inpatients: A systematic review of diagnostic accuracy studies.

Authors:  Aljoscha Benjamin Hwang; Stefan Boes; Thomas Nyffeler; Guido Schuepfer
Journal:  PLoS One       Date:  2019-07-25       Impact factor: 3.240

10.  Correlation Between Vision and Cognitive Function in the Elderly: A Cross-Sectional Study.

Authors:  Oriel Spierer; Naomi Fischer; Adiel Barak; Michael Belkin
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.